Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,217 | 38,829 | 43,781 | 27,179 | 14,265 |
| Marketable Securities | 10,989 | 12,086 | 23,217 | 50,380 | 72,506 |
| Receivables | N/A | 3,000 | N/A | N/A | N/A |
| TOTAL | $39,204 | $56,292 | $67,905 | $78,880 | $88,597 |
| Non-Current Assets | |||||
| PPE Net | 8,408 | 12,339 | 9,869 | 10,240 | 10,978 |
| Intangibles | 0 | 1,384 | 33,879 | 33,908 | 33,937 |
| Other Non-Current Assets | 7,560 | 9,571 | 7,366 | 7,647 | 7,920 |
| TOTAL | $15,968 | $23,294 | $51,114 | $51,795 | $52,835 |
| Total Assets | $55,172 | $79,586 | $119,019 | $130,675 | $141,432 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,758 | N/A |
| Accounts payable and accrued liabilities | 6,309 | 8,924 | 21,861 | 35,903 | 35,410 |
| Accrued Expenses | 4,206 | 5,585 | 2,593 | 2,190 | 2,868 |
| Other current liabilities | N/A | 296 | 296 | 296 | N/A |
| TOTAL | $12,337 | $16,623 | $26,473 | $41,867 | $40,839 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,209 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 296 |
| Other Non-Current Liabilities | 11,392 | 20,595 | 12,802 | 4,722 | 4,994 |
| TOTAL | $11,392 | $20,595 | $12,802 | $4,722 | $6,203 |
| Total Liabilities | $23,729 | $37,218 | $39,275 | $46,589 | $47,042 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,878 | 5,895 | 4,077 | 4,049 | 3,961 |
| Common Shares | 1,471 | 1,472 | 1,019 | 1,013 | 990 |
| Retained earnings | -676,431 | -655,640 | -608,957 | -601,913 | -586,706 |
| Other shareholders' equity | -30 | -27 | -9 | -1 | 3 |
| TOTAL | $31,443 | $42,368 | $79,744 | $84,086 | $94,390 |
| Total Liabilities And Equity | $55,172 | $79,586 | $119,019 | $130,675 | $141,432 |